Testing area foggers and room fogging systems

Area fogger and room fogging system testing connects liquid formulation, nozzle output, airflow, room geometry, and treated surfaces to measurable aerosol performance. When contact time, coverage, active recovery, or re-entry planning matters, EPA label-use expectations, protocol-defined deposition measurements, and ASHRAE airflow guidance can shape the study. The protocol defines the geometry and endpoints before testing. Programs are usually scoped when:

  1. Particle size distribution under ISO 13320 or ISO 21501 characterizes suspension time, settling behavior, respirable fraction, and room aerosol decay.
  2. Plume measurements can supplement EPA claim-support files by comparing nozzle, fan, throw-distance, and operating-mode behavior under a separately defined imaging protocol.
  3. Time-kill kinetics under ASTM E2315 or EPA OCSPP context screens active formulation performance before device-specific deposition studies.
  4. CFD transport studies under ASHRAE guidance evaluate airflow, recirculation, dead zones, settling, and sampling-location decisions for rooms or chambers.

Use fogging-system testing when room layout, ventilation, droplet size, surface wetness, contact time, or active recovery could change performance. Before the first fogging run, the protocol fixes the operating mode, geometry, sampling locations, controls, and how endpoints will be evaluated.

Core test menu for room fogging systems

Fogging programs usually combine aerosol output, deposition, plume, antimicrobial, and modeling work. The test set depends on the claim type, formulation risk, room geometry, and the decision the data must support.

Test method options

MethodStrengthsTradeoffAligned with
Room deposition and coverage mapping
  • Coupon, panel, or fixture layouts quantify surface loading and spatial coverage under a protocol matched to the room and deposition question.
  • Tracer or active recovery links fog output to room position, orientation, surface type, and off-target deposition.
Results apply to the defined room geometry, ventilation state, operating mode, and sampling grid.—
Fogger aerosol output characterization
  • PSD and concentration-time profiles show droplet size, suspension behavior, settling, and decay under ISO 13320 or ISO 21501 methods.
  • Nozzle, fan, formulation, and duty-cycle comparisons identify settings that shift airborne persistence or surface dose.
Optical and aerodynamic sizing must be tied to the defined liquid matrix and room conditions.
ISO 13320 / ISO 21501
Plume geometry and outlet imaging
  • High-speed imaging measures plume angle, width, outlet breakup, impingement, and throw distance under a device-specific imaging protocol.
  • Repeatable camera distance and lighting isolate nozzle or fan effects from room-scale dispersion.
Imaging explains plume behavior; pair with deposition data when coverage or active loading is the decision.—
Contact-time and time-kill screen
  • Liquid or surface kinetics quantify organism reduction versus exposure time under ASTM E2315 and EPA OCSPP context.
  • Neutralization and recovery controls separate active chemistry from device deposition effects before room-scale studies.
This supports formulation and claim planning; it does not replace EPA registration or label approval.
ASTM E2315 / EPA OCSPP 810.2200
CFD-supported room transport evaluation
  • CFD estimates aerosol transport, recirculation, settling, and dead zones under ASHRAE indoor airflow guidance.
  • Measured PSD, deposition, or concentration data provide validation points for sampling-location and scale-up decisions.
Model confidence depends on boundary conditions, device inputs, and measured data used to ground the simulation.
ASHRAE Guides

Setup configurations

Each fogging-system study starts with the device, formulation, room or chamber, and endpoint. Before runs begin, the protocol defines output mode, geometry, ventilation, sampling grid, controls, and analytical method. This keeps aerosol, deposition, time-kill, and model data comparable across conditions without changing the agreed data requirements during the study.

Device configuration

Fogger model, nozzle, fan setting, flow rate, output rate, duty cycle, run time, reservoir state, and operating mode documented per condition.

Room geometry

Chamber size, room layout, obstructions, ventilation rate, mixing state, sampling height, and surface orientation set before fogging starts.

Formulation & surfaces

Active concentration, tracer, solvent system, temperature, RH, coupon material, panel material, surface age, and neutralizer compatibility selected by endpoint.

Sampling locations

Air samplers, coupons, panels, filters, impingers, viable samplers, and imaging stations placed to answer coverage, exposure, or model-validation questions.

Sample numbers

Device count, replicate count, controls, pull timing, and decay intervals are defined during protocol development from expected variability and acceptance logic.

Quality frame for fogging-system studies

Fogging studies follow a documented quality system based on the lab accreditation and applicable method references. Device-specific deposition and imaging protocols define measurement controls and limits, with traceable records for kinetics, airflow interpretation, and report review.

  • ISO 17025AccreditedLaboratory competence, calibration traceability, method control, and uncertainty contributors.
  • ASTM E2315 / EPA OCSPP 810.2200AlignedTime-kill and disinfectant claim-support context for active-agent studies.
  • ASHRAE GuidesAlignedIndoor airflow and ventilation references for room transport modeling.

Key data outputs & reporting

Depending on the selected endpoints, fogging-system studies report PSD curves, airborne concentration-time profiles, plume images, deposition maps, surface loading, active recovery, viable reduction, and CFD outputs. These datasets connect device setup to measured room performance. Reports are formatted for development review, claim planning, sampling-plan design, or regulatory documentation. Extended deliverables include appendices for programs involving model validation, room scale-up, or comparator studies.

Primary outputs

  • PSD curves, Dv10 / Dv50 / Dv90, aerodynamic fractions, airborne concentration, decay, and settling summaries.
  • Plume angle, plume width, outlet behavior, throw distance, high-speed image observations, and run-to-run repeatability.
  • Deposition maps, surface loading, active or tracer recovery, wetness observations, and coverage by location or orientation.
  • Time-kill or viable reduction results with neutralization checks, recovery controls, and protocol-specific contact-time interpretation.
  • CFD velocity, concentration, recirculation, settling, dead-zone, and sampling-location visualizations when modeling is included.

Deliverables

#FormatContents
01PDF reportProtocol, setup, controls, deviations, endpoint tables, and interpretation limits.
02CSV / XLSX datasetsParticle, deposition, recovery, kinetics, or model-validation tables.
03Images / videoPlume frames, setup photos, deposition maps, and CFD exports.
Extended deliverables · multi-arm comparability · stability · predicate studies
  • Model-validation notes — Boundary conditions, mesh notes, validation points, and measured data used to ground CFD outputs.
  • Room-scale appendix — Sampling grid rationale, geometry notes, ventilation state, shadowed-zone findings, and scale-up limits.
  • Comparator summary — Side-by-side nozzle, fan, formulation, room, or operating-mode comparisons with endpoint-specific conclusions.

QA / QC & data integrity

Each fogging-system study has a QA/QC plan matched to the selected endpoints, formulation, and documentation pathway. Controls run alongside sample collection to keep particle, deposition, active-recovery, time-kill, and model data traceable from sample receipt through the final report. The report documents deviations and exclusions alongside the reported study results.

Device-off background, chamber blank, untreated coupon, neutralization control, positive control, or recovery control selected by endpoint.

Flow meters, particle instruments, balances, imaging scales, environmental sensors, and analytical instruments checked or calibrated before use.

Fogger settings, formulation preparation, room geometry, ventilation state, temperature, RH, and sampling locations documented per run.

Recovery efficiency, blank correction, analytical carryover, organism identity, neutralizer performance, and hold times controlled when required.

Chain of custody for devices, coupons, filters, extracts, raw files, images, calculations, CFD inputs, and report tables.

GLP-compliant documentation can be specified when the study is designed for that quality pathway.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
QualityDocumented study records
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

These answers cover questions fogger, disinfectant, and room-treatment teams ask when planning a study: which endpoints to combine, how rooms and sampling grids are defined, what affects the timeline, and what testing can and cannot establish. Most fogging programs need at least one planning decision about a custom chamber setup, coupon layout, neutralization approach, or CFD boundary condition.

Q.Which fogging-system test should I start with?
A.Start with the decision. PSD describes droplet size, while deposition measures coverage and loading. Plume imaging shows outlet behavior. Time-kill measures contact-time response, and CFD addresses transport or sampling-location questions.
Q.How are rooms or chambers configured?
A.The protocol defines room geometry, ventilation state, sampling locations, surface materials, run time, fogger settings, and environmental conditions. Replicate count is set during protocol development.
Q.Can ARE Labs support disinfectant fogging claims?
A.ARE Labs can support aerosol characterization, deposition, active recovery, time-kill, and protocol-defined efficacy endpoints. EPA registration, label approval, and complete claim packages must be addressed separately.
Q.What affects study duration?
A.The timeline depends on endpoint count, room or chamber availability, analytical method complexity, organism work, recovery validation, CFD scope, decay intervals, and the number of operating modes.
Q.What data will we receive?
A.Deliverables can include a PDF report, CSV or XLSX datasets, PSD curves, plume images, deposition maps, active recovery, viable reduction data, CFD outputs, QA/QC records, and setup photos.
Q.Does testing replace certification or regulatory approval?
A.No. Testing supports development, claim planning, and regulatory documentation. It does not replace electrical safety, software validation, labeling review, EPA registration, or product certification.

Standards & guidance

ARE Labs selects standards and guidance references that fit the study's particle sizing, antimicrobial kinetics, airflow interpretation, and QA documentation. Deposition mapping and plume imaging follow device-specific protocols with defined geometry, controls, and endpoints. For each measurement, the study plan identifies the applicable references and documents the rationale, acceptance criteria, and limits.